If you have trouble viewing the newsletter, please click here.

Section of Hospital pharmacist
“ONCOLOGY PHARMACY” Report
Dojran,17.04.2015

Association of Hospital pharmacist, Former Yugoslav Republic of Macedonia (FYROM) and the Working Group of oncology pharmacy organize Section of hospital pharmacists in Dojran, 17-19.04.2015 , with oncology  pharmacy as a main topic.

Educational meeting was consisted of two parts. In the first part of the meeting  was presented an overview of ESOP profile with its goals and activities. In addition the fifth edition of the QUAPOS and the importance of these standards in handling antineoplastic drugs were reported.  (O. Spasovska) Participants were introduced with the role of hospital pharmacist in the medical treatment of oncology patient, implementation of quality management oncology pharmaceutical services and

responsibility for patient care and safety of staff in all areas of cytotoxic therapy. (overview of current situation of hospital pharmacies in FYRO Macedonia).( M. Pendovska)

Special attention is paid to the safe management of antineoplastic drugs, recommendations, including those regarding equipment (personal protective equipment, labeling and packaging from point of receipt, administration, transportation and storage, spill kits, waste disposal).( S Filkova). Our colleague from Clinical hospital, Bitola , T.Dimitrovska  discussed about intervention of pharmacist regarding handling of cytotoxic drugs on non- oncology department at Clinical hospital Bitola.

The aim is to reduce the potential of harmful effects on health care personnel exposed to hazardous drugs.

We have a great presentation about oral chemotherapy, advantages and disadvantages, role of the pharmacist: how to inform patients about handling oral anticancer therapy, how to take tablets, possible treatment side effects and suggestions for remedial action, what to do in case of missed doses, safe storage of medicine…

Please follow the link below to read the complete report:
Section of Hospital pharmacist “ONCOLOGY PHARMACY” Report

 

ESOP goes Maghreb (Algeria)

NZW aktuell: Dear Reda, and Yacine, my best welcome here in Hamburg at the NZW. When did you arrive? How many hours took the flight?
Reda/Yacine: We arrived on January 21st 2014, the flight took about 4 hours.
NZW aktuell: Can you tell me something about the pharmacist education in Algeria?
Reda/Yacine: The pharmacist education is 6 years curriculum, sanctioned by PHD degree; currently the pharmacy graduation training is experiencing a profound reform.
NZW aktuell: Do the students learn anything concerning oncology pharmacy during his/her studies at the university?
Reda/Yacine: Pharmacy Oncology as a specialty in Algeria, however we do have some chapters in pharmacology, concerning this subject but this lack of training is detrimental and we felt it in our daily practice.

Please follow the link below to read the complete interview:

Interview with Dr. Reda Kessal and Yacine Mezaour, Algeria

ESOP goes Maghreb (Tunesia)

NZW aktuell: Dear Myriam, my best welcome here in Hamburg at the NZW. When did you arrive? How many hours took the flight?
Myriam Razgallah Khrouf: I arrived Wednesday, 21 January 2015 after 6 hours
flights.
NZW aktuell: Can you tell me something about the pharmacist education in Tunisia?
Myriam Razgallah Khrouf: In Tunisia we study 5 years with one year dispatched on 9 months of hospital training and 3 months in communotary pharmacy.

Please follow the link below to read the complete interview:

Interview with Dr. Myriam Razgallah Khrouf, Tunisia

Interview with Ewelina Korczowska from Poznan, Poland

Safe handling procedures should be closely monitored in all areas where antineoplastic drugs are delivered, stored, prepared, administered from and disposed of in order to reduce exposure of healthcare workers. Current knowledge levels on surface contamination with antineoplastic drugs in European hospitals in areas where these drugs are handled, is limited.

Please click at the picture to download the information sheet.

Regarding a lack of knowledge in these area Ewelina Korczowska together with the ESOP president Klaus Meier had the idea to conduct a study to evaluate and compare the surface contamination with antineoplastic drugs at various sites, including preparation (pharmacy) and administration (ward) areas in European hospitals.
Last Friday, during the ESOP-Meeting Ewelina presented the results of this pilot study. Later she gave Annette an interview for the NZW aktuell ...

Please follow the link below to read the complete interview:
Interview with Ewelina Korczowska, Poznan, Poland

 

If you don't want to recieve any further ESOP Newsletters, please click to unsubscribe.